View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Comment
July 21, 2020updated 02 Feb 2022 5:24am

Abbott receives FDA approval for next-generation ICD and CRT devices

By GlobalData Healthcare

On 6 July, Abbott won FDA approval for its next-generation Gallant implantable cardioverter-defibrillator (ICD) and cardiac resynchronisation therapy defibrillator (CRT-D) devices, equipped with Bluetooth technology and accompanying smartphone app.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The ongoing outbreak of Covid-19 has highlighted the advancement of healthcare, pushing innovation for patient-centred care and seamless communication of health information between the patient and provider. By connecting to a smartphone app via Bluetooth, the app is designed to make communication between doctors and patients more efficient, enhancing remote monitoring capabilities.

Prior to the pandemic, GlobalData expected the ICD and CRT-D market to grow at a compound annual growth rate (CAGR) of approximately 5%. GlobalData estimated that the impact of Covid-19 decreased the number of ICD and CRT-D implants by almost half for 2020, as a result of the temporary suspension of non-essential procedures. With the release of Abbott and Johnson & Johnson’s Q2 financials, both companies reported a recovery in cardiovascular procedures in the month of June to approximately 90% of the pre-Covid-19 procedure rate.

While procedures are returning to normal, social distancing and minimal contact is still encouraged, highlighting the importance of better communication tools between patients and their healthcare providers. Enhancing remote monitoring capabilities enables physicians to identify abnormal heart rhythms and provide earlier interventions. These additions to Abbott’s next generation of ICD and CRT-D devices may put them in an advantageous position over other devices and may allow the company to recover faster from the impact of the pandemic.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network